研究分层医学子组识别中的稳定性
G M Hair1, T Jemielita1, S Mt-Isa2
1BARDS, Merck & Co., Inc, Rahway, New Jersey, USA.
Pharmaceutical statistics
|June 26, 2024
概括
在分层医学中,评估子组稳定性至关重要. 本研究引入了一种评估子组稳定性的方法,发现当治疗效果不清楚时,患者子组的稳定性较差.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 小组分析确定治疗效果的异质性.
- 现有的方法往往忽略了子组分配稳定性.
- 像多重性和偏见这样的统计挑战是常见的.
研究的目的:
- 提出和评估一种方法来评估分组稳定性在分层医学.
- 识别影响子组不稳定的因素.
- 为了提高子组识别的稳定性.
主要方法:
- 用贝叶斯可信子组进行初始子组识别.
- 在患者和子组层面上使用非参数式启动来评估子组稳定性.
- 作为灵敏度分析的建议子组稳定性.
主要成果:
- 患者更有可能在不清楚的治疗效果下切换子组 ("跳跃者").
- 当治疗效果强大且令人信服时,子组表现出更大的稳定性.
- 确定了子组不稳定的潜在驱动因素.
结论:
- 小组稳定性分析对于在分层医学中验证已识别的小组至关重要.
- 拟议的方法适用于各种终点和识别技术,提高了子组发现的可靠性.
- 这种方法有助于更强大的个性化医疗策略.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
176
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
176
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125